The combination of OCT4 expression and short-term exposure to reprogramming media induces a state of transcriptional plasticity in human fibroblasts, capable of responding to changes in the extracellular environment that facilitate direct cell fate conversion toward lineage specific progenitors. Here we reveal that continued exposure of OCT4-induced plastic human fibroblasts to reprogramming media (RM) is sufficient to induce pluripotency. OCT4-derived induced pluripotent stem cell (iPSC OCT4 ) colonies emerged after prolonged culture in RM, and formed independently of lineage specific progenitors. Human iPSC OCT4 are morphologically indistinguishable from conventionally derived iPSCs and express core proteins involved in maintenance of pluripotency. iPSC OCT4 display in vivo functional pluripotency as measured by teratoma formation consisting of the three germ layers, and are capable of targeted in vitro differentiation. Our study indicates that acquisition of pluripotency is one of multiple cell fate choices that can be facilitated through environmental stimulation of OCT4-induced plasticity, and suggests the role of other reprogramming factors to induce pluripotency can be substituted by prolonged culture of plastic fibroblasts.
Introduction
Foundational cell fate reprogramming studies revealed ectopic expression of pluripotency-associated transcription factors (TF) OCT4, SOX2, KLF4, and c-MYC (OSKM) or OCT4, SOX2, NANOG, LIN28 (OSNL) in human fibroblasts (hFibs) cultured in pluripotent supportive conditions was sufficient for generation of induced pluripotent stem cells (iPSCs) possessing phenotypic, molecular, and functional characteristics akin to embryonic stem cells (ESCs) (Takahashi et al., 2007; Yu et al., 2007) . A multitude of reprogramming cocktails and methodologies have since been demonstrated to yield iPSCs from a range of adult cell types (Theunissen and Jaenisch, 2014) . Early modifications revealed ectopic expression of SKM could be functionally replaced by expression of structural homologs (Nakagawa et al., 2008) or chemical compounds (Li et al., 2011; Zhu et al., 2010) , and altogether bypassed if they were endogenously expressed in starting cell types (Eminli et al., 2008; Giorgetti et al., 2009; Kim et al., 2009 ). More recently, groups have identified that Nr5a2 (Heng et al., 2010) , E-cadherin (Redmer et al., 2011) and Gata3 (Montserrat et al., 2013; Shu et al., 2013) are capable of substituting for Oct4 when expressed with SKM; while others have replaced OS with Sall4 and Esrrb in combination with NL (Buganim et al., 2014) . Furthermore, complete replacement of ectopic expression of OSKM has been achieved using miR302/367 expression in combination with Hdac2 suppression (Anokye-Danso et al., 2011) , and a combination of seven small-molecule compounds in the mouse system (Hou et al., 2013) . However, despite these advances, a substitute that definitively replaces Oct4's functional activity and activates its gene targets in the absence of other reprogramming factors has not been identified. As such, OCT4's activity is indispensible for induction and maintenance of pluripotency (Orkin et al., 2008; Sterneckert et al., 2012) . Further supporting this concept, ectopic expression of high performance Oct4-VP16 transactivation domain fusion protein in mouse embryonic fibroblasts (MEF) is the only example of single factor reprogramming to achieve germline competent iPSCs without the addition of small molecules, miRNA, or ectopic/endogenous support by additional pluripotent factors .
Using similar cellular reprogramming principles, two paradigms exist toward achieving cell fate conversion. One approach relies on forced expression of lineage-specific TFs to facilitate lineage conversions (Lujan et al., 2012; Vierbuchen et al., 2010) . The alternative focuses on inducing an unstable or plastic cell state, demarcated by activation of multiple lineage specific gene expression programs, that is capable of responding to environmental cues (R. Mitchell et al., 2014; Orkin and Hochedlinger, 2011) . Strategies using short-term exposure to OSKM Kim et al., 2011) , OCT4 with small molecule substitutes of SKM Zhu et al., 2014) , and OCT4 alone (R. Mitchell et al., 2014; R. R. Mitchell et al., 2014; Szabo et al., 2010) in combination with reprogramming media (RM) have been employed toward achieving a cell state that responds to environmental cues. However, these approaches are molecularly distinct as the addition of pluripotency factors SKM convolutes plasticity induction by up-regulating early development and pluripotency genes (Maza et al., 2014; R. Mitchell et al., 2014) , indicating that OCT4 alone in combination with short-term exposure to RM is minimally sufficient to induce plasticity (R. Mitchell et al., 2014) . Accordingly, OCT4-induced plastic cells are capable of responding to environmental instruction toward derivation of neural and hematopoietic progenitors without traversing pluripotency (R. R. Mitchell et al., 2014; Szabo et al., 2010) . Although molecular/functional evidence indicates that transcriptional hallmarks of iPSCs are not observed in OCT4 plastic cells during short-term exposure to RM, whether continued culture in conditions known to support pluripotency is sufficient to up-regulate these programs remains to be elucidated.
Given that OCT4 activity and RM is minimally required to induce plasticity, and that this combination is also indispensible in the multitude of methodologies described above to achieve pluripotency reprogramming, we asked whether OCT4-induced plasticity was sufficient for pluripotency acquisition. To this end, we induced plasticity in human fibroblasts using OCT4 and short-term exposure to RM. Plastic fibroblasts were subjected to continued maintenance in pluripotent-supportive reprogramming media toward further influencing pluripotency acquisition. Using a combination of morphological, molecular, immunophenotypic, and functional assessments, we provide evidence that our deconvoluted OCT4-induced plasticity approach in combination with continued exposure to pluripotent supportive conditions is sufficient for inducing bona fide pluripotency in adult human fibroblasts.
Materials and methods
Human PSC and primary cell culture Human dermal adult forearm biopsies (5 × 5 mm) were obtained from consenting donors in accordance with Research Ethics Board-approved protocols at McMaster University; primary cultures were established as described (Villegas and McPhaul, 2005) . Primary human fibroblasts derived from breast dermal tissue were obtained from ScienCell Research Laboratories. All hFibs were cultured in hFib media [DMEM with 10% v/v fetal bovine serum (Neonatal Bovine Serum, HyClone), 1% v/v non-essential amino acid (NEAA; Gibco), and 1 mM L-glutamine (Gibco)].
iPSC OCT4 were derived on Matrigel (BD Biosciences) in reprogramming media (RM) [DMEM/F12 (Gibco) with 20% Knockout Serum Replacement (Gibco), 100 μM β-mercaptoethanol, 100 μM nonessential amino acid (Gibco), 1 mM L-glutamine (Gibco) supplemented with 16 ng/ml basic fibroblast growth factor (bFGF) and 30 ng/mL insulin-like growth factor (IGFII)]; and adapted to and cultured in mouse embryonic fibroblast conditioned media (MEFCM) supplemented with 10 ng/ml bFGF to stabilize pluripotency and enable colony expansion. iPSC OSNL were cultured on Matrigel (BD Biosciences) in MEFCM supplemented with 10 ng/ml bFGF. Cells were fed with fresh medium daily and confluent cultures were mechanically or enzymatically passaged every 5-7 days using 1 mg/ml Collagenase IV (Invitrogen).
Preparation of lentiviral vectors
pSIN-EF1α-OCT4-Puro plasmid developed by James A. Thomson (University of Madison-Wisconsin) and PL-SIN-EF1α-eGFP-Puro developed by James Ellis (University of Toronto) were obtained from Addgene. Virus containing plasmid was produced from HEK 293FT Cells with 2nd generation pMD2.G and psPAX2 packaging plasmids. Viral supernatant was harvested 72h after transfection and concentrated by ultracentrifugation.
Lentiviral transduction of primary human fibroblasts
Human adult dermal fibroblasts (10 4 adherent cells per well of a 12-well plate seeded on Matrigel the day before transduction) were incubated for 24 h with concentrated OCT4 or eGFP lentiviral vector in 0.5 mL hFib medium in the presence of 8 μg/ml polybrene (Sigma Aldrich). After 24 h of incubation, 2 mL of RM was added to the well. Following a further 24 h of incubation, lentiviral transduction conditions were replaced entirely with RM. Cells were maintained in this condition for prolonged culture with media changes and removal of areas of overgrown fibroblasts as necessary. iPSC colonies emerged between days 45 and 93, and were mechanically isolated and further expanded in MEFCM conditions.
Teratoma formation
To assess the development potential of iPSCs in vivo, iPSCs were collected by collagenase IV treatment and injected into the left testicle of NOD/SCID mice (approximately one well of a 6 well plate of 80% confluence for each mouse). At eight to ten weeks, teratomas were harvested, dissected and fixed with 4% paraformaldehyde. Samples were embedded in paraffin and processed with hematoxylin and eosin staining.
hEB formation and hematopoietic differentiation
Human embryoid bodies (hEBs) were generated by suspension culture as previously described (Hong et al., 2010) . Medium was changed with the hEB differentiation medium supplemented with hematopoietic growth factors (hGFs) as follows: 50 ng/ml granulocyte colony stimulating factor (G-CSF; Amgen, Inc.), 300 ng/ml stem cell factor (SCF; Amgen), 10 ng/ml interleukin-3 (IL-3; R&D systems), 10 ng/ml interleukin-6 (IL-6; R&D systems), 25 ng/ml BMP4 (R&D systems), and 300 ng/ml Flt-3 ligand (Flt-3L: R&D systems). hEBs were cultured for 16 days and medium was changed every three days. hEBs were enzymatically digested using Collagenase B, and single cells were collected. 10,000 cells were plated in Methocult H4434 medium. Colony forming units were identified and quantified on day 16.
Flow cytometry
Human Fibs and iPSCs were dissociated to single cell suspensions using TrypLE Express. Cells were stained using the following antibodies: CD34-PE or -FITC (Miltenyi Biotech), CD45-APC (Miltenyi Biotech) for hematopoietic EB differentiation experiments. For pluripotent analysis, cells were analyzed for the presence of SSEA3-PE and TRA-1-60-Alexa Fluor 647 (BD Pharmingen) for live cell surface markers. For detection of intracellular pluripotent transcription factors cells were fixed and permeabilized using the BD Cytofix/ Cytoperm kit. Cells were incubated overnight at 4°C with conjugated antibodies OCT4-Alexa Fluor 488, SOX2-Alexa Fluor 647 and NANOG-PE (BD Pharmingen). Flow cytometric analysis was performed using the BD LSRII Flow Cytometer with BD FACSDiva software and analyzed with FlowJo software (Tree Star Inc). Fluorescence activated cell sorting (FACS) was performed using BD FACSAria II cell sorter.
Real-time quantitative reverse transcription polymerase chain reaction
Total RNA was extracted from Fib, Fib OCT4 , whole iPSC cultures and FACS-isolated TRA-1-60 + iPSCs using the RNeasy kit (Qiagen), and cDNA was generated using qScript cDNA SuperMix (Quanta BioSciences). Oligonucleotides were designed for the detection of OCT4 (total, endogenous and exogenous), SOX2, NANOG and GAPDH (Table S1 ). RT-qPCR was performed on the BioRad CFX96 for 40 cycles for all marker genes. Relative gene expression was calculated using the ΔΔCt method. Endogenous GAPDH housekeeping gene was used for normalization.
Immunocytochemistry
Cells were washed once with 1 × PBS containing Calcium and Magnesium (Lonza) then fixed with 2% paraformaldehyde using the BD Cytofix fixation buffer. Cells were stained with SSEA3 or TRA-1-60 antibodies (BD Biosciences), and counterstained with DAPI.
PCR for provirus integration
Genomic DNA was extracted from 5 × 10 5 hFibs and iPSC OCT4 using the Qiagen DNeasy Blood & Tissue Kit. To demonstrate the presence or absence of transgenes in iPSC OCT4 and parent Fibs, primers specific to each transgene and IRES sequence were used to amplify the provirus. Primer sets were designed specifically to amplify OCT4, SOX2, LIN28, NANOG, KLF4, and cMYC provirus. pSIN4-EF2-O2S, pSIN4-EF2-N2L, and pSIN-EF2-K2M plasmids were used for positive controls. Primer sequences are indicated in Table S2 . PCR reactions were carried out using Thermo Maxima Hot Start Taq DNA Pol. Initial denaturation at 95°C (4 min) was followed by 35 cycles of denaturation at 95°C (30 s), annealing at 60°C (30 s), and elongation at 72°C (50 s), followed by a final elongation at 72°C (5 min).
DNA fingerprinting
To confirm the dermal and breast fibroblast origins of iPSC OCT4 lines, restriction fragment length polymorphism (RFLP) analysis was performed in the Centre for Applied Genomics Genetic Analysis Facility at SickKids Hospital (Toronto).
Array comparative genomic hybridization
Array comparative genomic hybridization (aCGH) was performed by the Princess Margaret Genomic Centre (University Health Network, Toronto) using an Agilent human genome CGH 4 × 44K microarray with CY3/CY5-labeled genomic DNA isolated from TRA-1-60 + iPSC OCT4 and sex-matched reference DNA. Data was analyzed on Partek Genomics Suite (v6.6) using the genome copy number segmentation algorithm on log2 ratios converted to copy number, with parameters set to: 15 minimum genomic markers, 0.001 P-value threshold, 0.5 signal to noise ratio, and diploid copy number range from 1.5 to 2.5.
Results
Continued exposure of plastic human fibroblasts to pluripotent supportive conditions is sufficient for the generation of iPSCs Plastic human fibroblasts (hFibs) generated through ectopic expression of OCT4 and short-term exposure to reprogramming media (RM) are capable of responding to lineage-specific culture conditions toward direct conversion to hematopoietic and neural progenitor cells without first initiating or establishing pluripotency (R. R. Mitchell et al., 2014; Szabo et al., 2010) . Despite the lack of evidence that OCT4 plastic cells induce early transcriptional hallmarks of iPSCs, we asked whether pluripotency could be acquired through continued culturing of OCT4 plastic cells in pluripotent supportive conditions. Accordingly, hFibs were transduced with OCT4 (hFib OCT4 ) and cultured in RM to induce plasticity (Figs. S1A and B) (R. Mitchell et al., 2014) . Consistent with our previous findings, hFib OCT4 morphologies transitioned from bipolar-elongated to compact-cuboidal, and this transition was dependent on the combination of OCT4 and RM (Fig. S1C ), suggesting that plasticity had been induced (R. Mitchell et al., 2014) . In addition to predictive morphological features, total populations of plastic hFib OCT4 have been identified by their acquisition of lineage specific gene expression profiles (R. Mitchell et al., 2014) and by expression of lineage-specific proteins (R. Mitchell et al., 2014; Szabo et al., 2010) . For example, expression of the pan-hematopoietic marker CD45 (Woodford-Thomas and Thomas, 1993) identifies a subset of plastic cells in RM that are capable of responding to hematopoietic culture conditions and undergoing direct conversion to the hematopoietic lineage (R. Mitchell et al., 2014; Szabo et al., 2010) . To further corroborate our morphological assessment that plasticity had been achieved in our current study, we performed flow cytometric analyses on total cell cultures at Day 24 ( Fig. 1A) using CD45 expression as a marker of plasticity induction. Flow cytometric analyses revealed CD45 expression on a subpopulation of cells (Fig. 1B) , further indicating that plasticity had been achieved. Moreover, we confirmed that plastic hFib OCT4 were devoid of pluripotent markers SSEA3 and TRA-1-60 at this time ( Fig. 1B) (Takahashi et al., 2007) . Having confirmed that OCT4 plasticity had been induced, we continued to culture Fib OCT4 in RM, also known to support pluripotency, and monitored these cultures for the emergence of iPSC-like cells. After continued maintenance in RM ranging from 45 to 93 days, flat dense colonies of cells with large nuclei and scant cytoplasm resembling iPSCs were observed (Figs. 1C, S1D and E). Flow cytometric and immunocytochemistry analyses revealed that these colonies expressed pluripotent markers SSEA3 and TRA-1-60 ( Figs. 1D and E) . In contrast, we did not detect the emergence of TRA-1-60 + colonies from mechanically isolated cultures of CD45 + plastic fibs cultured in RM for the same period of time ( Figs. S2A and B ), suggesting that CD45 + plastic fibs were not a reprogramming intermediate on the path to iPSCs (Szabo et al., 2010) . Next, we attempted to expand SSEA3 + TRA-1-60 + colonies through clonal isolation and maintenance in RM. However, these conditions were not conducive to expansion, resulting in cultures that did not meet our morphological standards for PSC cultures (similar to Fig. 1F ) (Bendall et al., 2007; Lee et al., 2013) . In an effort to assess if pluripotency could be stabilized within these cells toward facilitating clonal expansion in the absence of mouse embryonic fibroblasts (MEF), we passed Fib OCT4 -derived SSEA3 + TRA-1-60 + colonies evenly into either RM or MEF conditioned medium (MEFCM) supplemented with bFGF (Bendall et al., 2007) . Culture in MEFCM resulted in stabilization of pluripotency and enabled colony expansion within two passages as evidenced by restoration of standard PSC culture morphology and a significant increase in frequency of SSEA3 + and TRA-1-60 + cells as compared to the culture concurrently maintained in RM (Figs. 1F-J). Given their morphological features and robust expression of pluripotency-associated markers, we termed these cells iPSC OCT4 .
In an effort to ensure that iPSC OCT4 colony generation was attributed to ectopic expression of OCT4 we generated restriction fragment length polymorphism (RFLP) signatures of iPSC OCT4 and compared them to that of the starting hFib populations (Figs. 1K and S1G) confirming that iPSC OCT4 generation was not a result of culture cross contamination with existing PSC lines from our lab. Furthermore, polymerase chain reaction (PCR) analysis performed on genomic DNA isolated from iPSC OCT4 colonies revealed the exclusive presence of OCT4 provirus integration (Fig. 1L) , indicating that iPSC OCT4 were derived from hFib OCT4 . To confirm that the formation of iPSC colonies was directly correlated to ectopic expression of OCT4 alone we used flow cytometric analysis to assess pluripotent marker expression in non-transduced, parent hFibs. These analyses revealed no expression of endogenous OCT4, SOX2, or NANOG (Fig. 1M) , indicating that iPSC OCT4 generation was attributed to OCT4-induced plasticity induction, and not due to OCT4 expression in combination with endogenous pluripotent TF expression as previously demonstrated in neural progenitors (Kim et al., 2009 ). Together, these data confirm that iPSC OCT4 are derived from plastic OCT4-expressing adult human fibroblasts. iPSC OCT4 possess biomolecular, immunophenotypic and functional characteristics similar to iPSC OSNL We next sought to further validate the pluripotent features of iPSC OCT4 through comparison to iPSC generated previously in our lab using a multi-factor approach (iPSC OSNL ) (Hong et al., 2011) . To assess the expression of core pluripotency factors OCT4, SOX2, and NANOG (Orkin et al., 2008) , cultures of iPSC OCT4 and iPSC OSNL with comparable confluence and undifferentiated cell content ( Fig. 2A) were collected for gene expression and flow cytometric analyses. Endogenous expression of OCT4, as well as activation of endogenous SOX2 and NANOG transcripts, was observed in both iPSC lines (Fig. 2B) ; demonstrating that exogenous OCT4-mediated reprogramming is capable of activating pluripotent markers similar to multi-factor approaches used for pluripotent reprogramming (Chan et al., 2009 ). Furthermore, in three iPSC OCT4 lines derived from three separate human donors, OCT4 transgene expression was decreased relative to Fib OCT4 and provided minimal contribution to total OCT4 expression similar to that observed in iPSC OSNL (Yu et al., 2007) and iPSC OSKM (Chan et al., 2009; Takahashi et al., 2007) (Fig. 2C) . At the protein level, flow cytometric analyses revealed that activated expression of OCT4, SOX2, and NANOG, and expression of SSEA3 and TRA-1-60 cell surface pluripotent markers was similar between iPSC OCT4 vs iPSC OSNL cultures maintained at comparable undifferentiated colony densities ( Figs. 2A and D) ; this protein-level pluripotent marker expression was also observed in lower colony-density cultures of additional iPSC OCT4 lines derived from independent hFib sources (Fig. S1F) . Together, these molecular and phenotypic characteristics possessed by three independent iPSC OCT4 lines are consistent with "type III" bona fide iPSCs (Chan et al., 2009 ). Next, we used array comparative genomic hybridization to assess the karyotype of three independent iPSC OCT4 lines, at a genomic resolution beyond that obtained using standard cytogenetic procedures (Elliott et al., 2010; Martins-Taylor et al., 2011) . One iPSC OCT4 line was devoid of copy number variation ( Fig. 2E) , while the others possessed two and five amplifications, the majority of which are found in regions/chromosomes that are recurrently altered in cultured hPSCs (Fig. S3A) (Baker et al., 2007; Martins-Taylor et al., 2011; Taapken et al., 2011) . While these results indicate that iPSC OCT4 reprogramming is not dependent on the presence or acquisition of genetic abnormalities to initiate pluripotency and is similar to OSKM and OSNL pluripotent reprogramming (Martins-Taylor et al., 2011; Takahashi et al., 2007; Yu et al., 2007) , it is possible that the incidence of genetic abnormalities may be increased due to prolonged culture required for pluripotency acquisition using OCT4 alone. Together these results demonstrate that iPSC OCT4 possess the biomolecular hallmarks of pluripotency similar to iPSCs generated using a multi-factor reprogramming approach.
The most stringent test for evaluating pluripotency of human cells is the in vivo teratoma formation assay (Thomson et al., 1998) . To evaluate whether activation of the core pluripotent network conferred functional pluripotent differentiation capacity in iPSC OCT4 , we assessed their ability to generate teratomas consisting of tissue derivatives from the three germ layers (ectoderm, endoderm, and mesoderm) in immune deficient mice. Cultures of iPSC OCT4 and iPSC OSNL , with comparable confluence and undifferentiated cell content based on morphological observation and SSEA3 expression (Figs. S3B and C), were prepared for intratesticular injection. Consistent with bona fide PSC potential, both iPSC OCT4 and iPSC OSNL formed teratomas comprised of all three germ layers (Figs. 2F and S3D and E) indicating that iPSC OCT4 are functionally pluripotent in vivo.
In addition to in vivo differentiation potential, we further investigated if iPSC OCT4 were capable of responding to targeted in vitro differentiation conditions. Based on our established competencies in hematopoietic differentiation of PSCs (Chadwick et al., 2003; Hong et al., 2010) , we vigorously assessed the in vitro hematopoietic capacity of iPSC OCT4 . Using an embryoid body (EB) based differentiation assay (Fig. 2G ) (Chadwick et al., 2003) , cultures of iPSC OCT4 and iPSC OSNL were assessed for their ability to generate CD34 + CD45 + hematopoietic progenitors. Both iPSC OCT4 and iPSC OSNL underwent differentiation toward the hematopoietic lineage, generating similar frequencies of CD34 + CD45 + putative hematopoietic progenitors (Figs. 2H and I) . To further characterize the resulting putative hematopoietic progenitors and evaluate whether they shared similar functional capacity to differentiate into mature hematopoietic cells we subjected them to colony forming unit (CFU) assays. The frequency of CD34 + CD45 + progenitors with CFU potential was similar between blood progenitors derived from iPSC OCT4 and iPSC OSNL (Fig. 2J ). Moreover, both iPSC OCT4 and iPSC OSNL derived progenitors displayed multilineage differentiation into all of the mature hematopoietic cell types read out by the CFU assay ( Fig. 2K) , which was further confirmed by Giemsa-Wright assessment of single cell morphologies (Figs. 2L and M) . Taken together these results confirm that like iPSC OSNL , iPSC OCT4 are capable of responding to targeted differentiation cues resulting in the generation of mature tissue types in vitro, further validating this unique source of pluripotent stem cells.
Discussion
Here we show that continued (albeit prolonged) culture of plastic hFib OCT4 in RM media is sufficient for induction of pluripotency. Importantly, iPSC OCT4 possess morphological, biomolecular, and functional hallmarks of bona fide PSCs (K.R. Salci et al., 2015) . Building on our previous works using OCT4 to induce a state of plasticity required for cell fate conversion (R. Mitchell et al., 2014; R. R. Mitchell et al., 2014; Szabo et al., 2010), our current findings highlight that pluripotency represents another cell fate choice for plastic human fibroblasts ( Fig. 3 ) and provides further example that cell fate alteration through plasticity induction can be achieved without additional TFs Kim et al., 2011; Li et al., 2013) or small molecules Zhu et al., 2014) .
Despite the myriad of methodologies to induce pluripotency in human somatic cells (Anokye-Danso et al., 2011; Buganim et al., 2014; Eminli et al., 2008; Giorgetti et al., 2009; Heng et al., 2010; Hou et al., 2013; Kim et al., 2009; Li et al., 2011; Montserrat et al., 2013; Nakagawa et al., 2008; Redmer et al., 2011; Shu et al., 2013; Takahashi et al., 2007; Theunissen and Jaenisch, 2014; Yu et al., 2007; Zhu et al., 2010) , exogenous delivery or endogenous activation of OCT4 is indispensible for reprogramming to pluripotency. Furthermore, we are unaware of any report suggesting that iPSCs can be generated without the use of pluripotent-supportive reprogramming media. As we have demonstrated that pluripotency is another destination of plastic human fibroblasts, we suggest that conventional reprogramming to pluripotency (Takahashi et al., 2007; Yu et al., 2007) relies on the combination of OCT4-induced plasticity and pluripotent media instruction, and is expedited or further specified by the addition of pluripotent-specifying TFs (SKM, SNL). We also propose that this could explain why pluripotency is transiently acquired during OSKM-mediated "transdifferentiation" (Maza et al., 2014) . Given the reduced complexity of our reprogramming system, we feel OCT4 -induced plasticity represents an ideal model to elucidate the governing mechanisms that allow for alteration of cell fate upon manipulation of native transcriptional programs toward both lineage specific progenitors and pluripotent stem cells alike.
Figure 3
Acquisition of pluripotency is one of multiple cell fate choices that can be facilitated through environmental stimulation of OCT4 induced plasticity. Schematic placing the derivation of iPSC OCT4 from plastic cells into context with previous demonstrations of cell fate conversion using OCT4 plastic cells. Given the stochastic nature of cellular fate reprogramming of adult human primary tissues, the range in timing of observed OCT4-induced plasticity events is illustrated by dotted bar lines along the timeline.
